fda 503a bulks list category 2 bpc-157 just got voted in favor to be added to the Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA Pharmacy Compounding Committee Votes

FDA Pharmacy Compounding Committee Votes on Peptide Policy John Hoekman posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for fda category 2 bulk drug substances list bpc 157 Industry Update: Interim 503A and 503B Bulks

SKU: 55209758828 · From southroadsurgery.com.au